AGILENT TECHNOLOGIES INC's ticker is A and the CUSIP is 00846U101. A total of 894 filers reported holding AGILENT TECHNOLOGIES INC in Q3 2023. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Menard Financial Group LLC | 2,920 | $326,474 | 0.47% |
| LBP AM SA | 189,011 | $21,135,210 | 0.47% |
| Stanley-Laman Group, Ltd. | 24,469 | $2,736,124 | 0.47% |
| ROYAL LONDON ASSET MANAGEMENT LTD | 1,281,546 | $143,283,251 | 0.46% |
| GRIMES & COMPANY, INC. | 107,261 | $11,993,936 | 0.46% |
| InTrack Investment Management Inc | 4,572 | $511,241 | 0.45% |
| PARNASSUS INVESTMENTS, LLC | 1,624,529 | $181,654,833 | 0.44% |
| STATE FARM MUTUAL AUTOMOBILE INSURANCE CO | 3,950,809 | $441,779,462 | 0.44% |
| IAM Advisory, LLC | 11,331 | $1,267,060 | 0.44% |
| MASSACHUSETTS FINANCIAL SERVICES CO /MA/ | 11,076,270 | $1,238,548,511 | 0.43% |
| Hyperion Partners, LLC | 4,482 | $501,177 | 0.43% |
| Paragon Advisors, LLC | 9,350 | $1,045 | 0.43% |
| MASTRAPASQUA ASSET MANAGEMENT INC | 32,708 | $3,657,409 | 0.43% |
| GIRARD PARTNERS LTD. | 33,225 | $3,715,219 | 0.42% |
| Exchange Bank | 3,836 | $428,941 | 0.41% |
| Boston Trust Walden Corp | 435,218 | $48,666,077 | 0.41% |
| CASCADE INVESTMENT GROUP, INC. | 3,842 | $429,562 | 0.40% |
| Pensionfund Sabic | 10,300 | $1,152 | 0.40% |
| ZRC WEALTH MANAGEMENT, LLC | 4,196 | $469,197 | 0.40% |
| Eversept Partners, LP | 41,825 | $4,676,872 | 0.40% |
About AGILENT TECHNOLOGIES INC
Agilent Technologies Inc. is a leading global provider of life sciences, diagnostics, and applied chemical markets. The company was founded in 1999 and is headquartered in Santa Clara, California. Agilent's mission is to improve the quality of life by enabling people to live healthier and longer.
Agilent's products and services are used in a wide range of applications, including pharmaceuticals, biotechnology, environmental testing, food testing, and forensics. The company's portfolio includes instruments, software, consumables, and services that enable customers to analyze, identify, and quantify substances with accuracy and precision.
Agilent has a strong commitment to innovation and invests heavily in research and development. The company has a team of over 1,200 scientists and engineers who work on developing new technologies and improving existing ones. Agilent's focus on innovation has resulted in numerous breakthroughs, including the development of the first commercial gas chromatograph and the first commercial atomic absorption spectrophotometer.
Agilent is also committed to sustainability and corporate responsibility. The company has set ambitious goals to reduce its environmental impact and has implemented a number of initiatives to achieve these goals. Agilent is also committed to ethical business practices and has a strong code of conduct that guides its employees' behavior.
In conclusion, Agilent Technologies Inc. is a leading provider of life sciences, diagnostics, and applied chemical markets. The company's commitment to innovation, sustainability, and corporate responsibility has made it a trusted partner for customers around the world. With a strong focus on research and development, Agilent is well-positioned to continue driving innovation and improving the quality of life for people everywhere.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
External links
This page lists AGILENT TECHNOLOGIES INC's shareholders in Q3 2023. To view AGILENT TECHNOLOGIES INC's shareholder history, click here.